SCHEMBL283202

SCHEMBL283202

CCCCN(CCCC)C(CCO)N(CCCC)CCCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
LMNA P02545 3/20 0.36
TSHR P16473 2/20 0.36
HSD17B10 Q99714 1/20 0.36
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
MMP2 P08253 3/20 0.34
MMP1 P03956 1/20 0.34
MMP3 P08254 1/20 0.34
MMP8 P22894 1/20 0.34
PSMD14 O00487 2/20 0.32
PLA2G1B P04054 2/20 0.32
ATG4B Q9Y4P1 2/20 0.32
HSP90AA1 P07900 1/20 0.32
RAD52 P43351 1/20 0.32
DNM1 Q05193 2/20 0.32
ALDH2 P05091 1/20 0.32
CA12 O43570 1/20 0.32
CA1 P00915 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10794262 0.79 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL3104058 0.79 ALDH1A1 (0.38) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL2842761 0.77 LMNA (0.44) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL4263660 0.76 MMP1 (0.30) MMP2MMP1MMP3MMP8
Hydrochloric Acid SCHEMBL14778003 0.76 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
Iodide SCHEMBL14777842 0.76 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL754545 0.76 MMP1 (0.39) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
Bromide SCHEMBL14777926 0.76 ALDH1A1 (0.35) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10
SCHEMBL4265723 0.74 PLA2G1B (0.32) TSHRPLA2G1BDNM1
Fluoride SCHEMBL30636245 0.74 LMNA (0.43) ALDH1A1SMN1; SMN2LMNATSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120108828-A1 SYNTHESIS OF DRONEDARONE AND SALTS THEREOF USV Limited, B.S.D. Marg (IN) 2012-05-03 US disclosed
EP-2428511-A1 Synthesis of dronedarone and salts thereof USV Limited (IN) 2012-03-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120108828-A1 SYNTHESIS OF DRONEDARONE AND SALTS THEREOF CYP3A4, CYP2D6, CYP3A43 ALDH1A1 1001/4885SMN1; SMN2 3861/4885LMNA 740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.